The new offering represents part of the company's responses to growing demands for a wide range ofgenomic and sequencing services in the nation's healthcare and life science space, consolidating its ...

The DNA synthesis market is growing as demand for DNA synthesis products and services increases across various applications, with significant growth in North America, Europe, and Asia Pacific.Austin, ...

Cell-free DNA can be used for non-invasive cancer detection and disease monitoring to enhance personalized medicine.

Advisory Committee has endorsed first ever locally made Monkey Pox (Mpox) test from Morocco in efforts to boost Africa's health self-reliance and outbreak response.

Lucid Diagnostics Inc. ( (LUCD) ) has released its Q3 earnings. Here is a breakdown of the information Lucid Diagnostics Inc. presented to its ...

A new study presents "Evo" – a machine learning model capable of decoding and designing DNA, RNA, and protein sequences, from ...

Lucid reports record quarterly EsoGuard® revenue and completes clinical evidence package for imminent submission to formally seek Medicare coverage Veris Health completes ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good morning, and welcome to the Lucid Diagnostics Third Quarter ...

A new study presents “Evo” – a machine learning model capable of decoding and designing DNA, RNA, and protein sequences, from molecular to genome scale, with unparalleled accuracy. Evo’s ability to ...

A diagnostic test developed by researchers at the University of California San Francisco aims to help physicians identify causes of severe infections by analyzing DNA and RNA to detect a range of ...